5-Amino-1MQ (10 mg Vial) Administration Guide

Step-by-step instructions for preparing and administering 5-Amino-1MQ, a targeted NNMT enzyme blocker investigated for metabolic performance and fat utilization.

Preparation

Dosing & Reconstitution Guide

Detailed instructions for mixing solution and daily administration

Injection Schedule (2 mL = 5 mg/mL)

Dosing schedule: Administer once or twice daily via subcutaneous injection. Given the substance's half-life of about 3.8–6.9 hours, twice-daily injections might offer more consistent enzyme inhibition. Important: One 10 mg vial lasts just 2–4 days at these amounts.

Solution Preparation

1. Take vial out of freezer (−20 °C / −4 °F) and let it warm to room temperature for 15–20 minutes.
2. Using sterile syringe, withdraw 2.0 mL bacteriostatic water.
3. Inject gently along the vial wall to prevent bubbles.
4. Swirl gently until fully dissolved—liquid should be transparent (avoid shaking).
5. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light; use within 2–4 weeks.

Biological Action

5-Amino-1MQ is a synthetic molecule that specifically targets and blocks the activity of NNMT, an enzyme responsible for transferring methyl groups to nicotinamide using SAM as the methyl source. When metabolic issues occur, NNMT tends to be more active in fat cells, using up nicotinamide and lowering NAD+ supplies.

When NNMT gets blocked by this compound, more nicotinamide becomes available for NAD+ production, which then stimulates SIRT1 pathways linked to mitochondrial growth and fat burning processes. Early research shows that reducing NNMT activity can help prevent weight increases from high-calorie diets and enhance metabolic function without changing eating habits.

Observed Effects & Safety

Findings reported in initial scientific studies and animal research.

• Could help decrease body fat while maintaining muscle tissue in laboratory animals
• Linked to increased NAD+ concentrations and enhanced SIRT1 function in early research
• Improved muscle strength noted in older mice when used alongside physical activity
• Usually well accepted; some experience mild headaches, temporary nervousness, or local injection discomfort
• Extended human safety information unavailable; substance is still under investigation

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

1. Clean the vial stopper and skin with alcohol; allow to dry.
2. Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue.
3. Do not aspirate for subcutaneous injections; inject slowly and steadily.
4. Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
5. Slow injection may minimize any stinging sensation associated with the compound.

Key Considerations

Essential guidelines for proper handling and consistent results.

• Employ fresh sterile insulin syringes for every dose; discard in approved sharps containers.
• Change injection locations (stomach area, thighs, upper arms) to minimize skin irritation.
• Administer gradually; slight burning may happen because of the molecular composition.
• Record each dose amount and rotation pattern to ensure reliable results.
• The 10 mg vial works well for brief tolerance testing; longer studies need several vials.

References